Screener
Opko Health OPK Cash & Equivalents
Discontinued — last reported Q2 '24
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Opko Health in its filing.
Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.
The source filing: Opko Health’s 10-Q, filed August 7, 2024.
- Filed
- Aug 7, 2024
- Fiscal quarter
- Q2 FY2024
- Calendar quarter
- Q2 2024
- Accession
- 0001437749-24-025185
| Line item | June 30, 2024 | December 31, 2023 |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $40,576 | $95,881 |
| Accounts receivable, net | 105,313 | 123,379 |
| Inventory, net | 60,153 | 65,697 |
| Other current assets and prepaid expenses | 32,288 | 24,519 |
| Assets held for sale | 119,651 | — |
| Total current assets | 357,981 | 309,476 |
Item 1. Financial Statements
FAQ
- What is Opko Health's cash & equivalents?
- Opko Health (OPK) reported cash & equivalents of $40.58M in Q2 2024.
- How has Opko Health's cash & equivalents changed year-over-year?
- Opko Health's cash & equivalents decreased by 62.5% year-over-year, from $108.11M to $40.58M.
- What is the long-term trend for Opko Health's cash & equivalents?
- Over 3 years (2020 to 2023), Opko Health's cash & equivalents has grown at a 9.9% compound annual growth rate (CAGR), from $72.21M to $95.88M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Opko Health's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude